Brand

Otsuka Pharmaceutical Development & Commercialization, Inc. Recalls

2 recalls on record. Search official CPSC, FDA, and USDA datasets for every recall issued for Otsuka Pharmaceutical Development & Commercialization, Inc..

2Total Recalls
0Critical
22,063Units Affected
Sep 17, 2018Most Recent
All Recalls

Every Otsuka Pharmaceutical Development & Commercialization, Inc. Recall

Sorted by most recent. Click any recall for full details.

2 recalls
RecallFDA
Otsuka Pharmaceutical Development & Commercialization, Inc.
treatNOW ABILIFY (aripiprazole) / ABILIFY MAINTENA 400-mg (aripiprazole) for extended release injectable suspension. Kit contents 2 packs...
Injectable Drugs·4,738 affected·Sep 17, 2018
RecallFDA
Otsuka Pharmaceutical Development & Commercialization, Inc.
treatNOW ABILIFY (aripiprazole) and ABILIFY MAINTENA (aripiprazole) 400MG for extended release injectable suspension. Kit Contents: 2 pac...
Injectable Drugs·17,325 affected·Sep 17, 2018